The coronavirus vaccine from Sanofi and GlaxoSmithKline will receive up to $2.1 billion from Operation Warp Speed — here's how it compares to other candidates

Drug makers Sanofi and GlaxoSmithKline are set to receive up to $2.1 billion in funding for their potential coronavirus vaccine. The funding comes from Operation…

Read More The coronavirus vaccine from Sanofi and GlaxoSmithKline will receive up to $2.1 billion from Operation Warp Speed — here's how it compares to other candidates